Meta-analyses of randomised controlled trials (RCT) of warfarin and low molecular weight heparin (LMWH) for the prevention of venous thromboembolism (VTE) and death in cancer patients

Keith Wheatley; Laura Buckley; Robert Hills; AM Young

Meta-analyses of randomised controlled trials (RCT) of warfarin and low molecular weight heparin (LMWH) for the prevention of venous thromboembolism (VTE) and death in cancer patients

Keith Wheatley
, Laura Buckley
, Robert Hills
, AM Young

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Pages	267A-267A
Publication status	Published - 1 Nov 2005
Event	47th Annual Meeting of the American-Society-of-Hematology, Dec 10-13, 2005. Atlanta, Ga - Duration: 1 Nov 2005 → …

Conference

Conference	47th Annual Meeting of the American-Society-of-Hematology, Dec 10-13, 2005. Atlanta, Ga
Period	1/11/05 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{861da1127ef34cf7ad8d3a3bc18bd1bd,

title = "Meta-analyses of randomised controlled trials (RCT) of warfarin and low molecular weight heparin (LMWH) for the prevention of venous thromboembolism (VTE) and death in cancer patients",

author = "Keith Wheatley and Laura Buckley and Robert Hills and AM Young",

year = "2005",

month = nov,

day = "1",

language = "English",

pages = "267A--267A",

note = "47th Annual Meeting of the American-Society-of-Hematology, Dec 10-13, 2005. Atlanta, Ga ; Conference date: 01-11-2005",

}

Meta-analyses of randomised controlled trials (RCT) of warfarin and low molecular weight heparin (LMWH) for the prevention of venous thromboembolism (VTE) and death in cancer patients. / Wheatley, Keith; Buckley, Laura; Hills, Robert et al.
2005. 267A-267A Abstract from 47th Annual Meeting of the American-Society-of-Hematology, Dec 10-13, 2005. Atlanta, Ga.

Research output: Contribution to conference (unpublished) › Abstract

TY - CONF

T1 - Meta-analyses of randomised controlled trials (RCT) of warfarin and low molecular weight heparin (LMWH) for the prevention of venous thromboembolism (VTE) and death in cancer patients

AU - Wheatley, Keith

AU - Buckley, Laura

AU - Hills, Robert

AU - Young, AM

PY - 2005/11/1

Y1 - 2005/11/1

M3 - Abstract

SP - 267A-267A

T2 - 47th Annual Meeting of the American-Society-of-Hematology, Dec 10-13, 2005. Atlanta, Ga

Y2 - 1 November 2005

ER -